Clinical trial
Islet Autoantibody Early Detection in At-risk Children/Adolescents to Predict Type 1 Diabetes: a Cohort Study in Gulf Countries
NCT07038473 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Islet Autoantibody Early Detection in At-risk Children/Adolescents to Predict Type 1 Diabetes: a Cohort Study in Gulf Countries
- Lead sponsor
- Sanofi
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 17, 2025
- Completion date
- December 25, 2026
- Enrollment
- 3,500 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes